Drug intelligence / Profile preview

RU78262

Development stage: Unknown
Modality: Small Molecules

Overview

RU78262 is a small molecule experimental compound classified as a phenyl phosphate derivative. Its chemical formula is C7H7O5P, and it is also known as 2-formylphenoxyphosphonic acid. The compound has been studied primarily as a research tool and does not have any approved medical indications or clinical trial activity beyond the preclinical stage. One reported mechanism of action is inhibition of the proto-oncogene tyrosine-protein kinase Src, though its pharmacological effects in humans are not established[1][4][5]. It has no known brand names or marketed formulations.

Other names: 2-formylphenyl dihydrogen phosphate2-phosphonooxy-benzaldehyde2-formylphenoxyphosphonic acidPhosphoric acid 2-formylphenyl ester(2-formylphenyl) dihydrogen phosphate

Targets

SRC (Proto-oncogene tyrosine-protein kinase Src)

Beyond the preview

Go deeper on RU78262.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RU78262.

Explore the full profile